These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
549 related items for PubMed ID: 16258106
21. Effectiveness of treatments for metastatic uveal melanoma. Augsburger JJ, Corrêa ZM, Shaikh AH. Am J Ophthalmol; 2009 Jul; 148(1):119-27. PubMed ID: 19375060 [Abstract] [Full Text] [Related]
22. Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2. Becker JC, Terheyden P, Kämpgen E, Wagner S, Neumann C, Schadendorf D, Steinmann A, Wittenberg G, Lieb W, Bröcker EB. Br J Cancer; 2002 Oct 07; 87(8):840-5. PubMed ID: 12373596 [Abstract] [Full Text] [Related]
23. Response of patients with metastatic uveal melanoma to combined treatment with fotemustine and sorafenib. Niederkorn A, Wackernagel W, Artl M, Schwantzer G, Aigner B, Richtig E. Acta Ophthalmol; 2014 Dec 07; 92(8):e696-7. PubMed ID: 24774993 [No Abstract] [Full Text] [Related]
24. Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome. Schuster R, Lindner M, Wacker F, Krössin M, Bechrakis N, Foerster MH, Thiel E, Keilholz U, Schmittel A. Melanoma Res; 2010 Jun 07; 20(3):191-6. PubMed ID: 20335820 [Abstract] [Full Text] [Related]
25. Liver metastases from uveal melanoma: clinical experience of hepatic arterial infusion of cisplatin, vinblastine and dacarbazine. Melichar B, Voboril Z, Lojík M, Krajina A. Hepatogastroenterology; 2009 Jun 07; 56(93):1157-62. PubMed ID: 19760961 [Abstract] [Full Text] [Related]
26. Stage-IV melanoma and pulmonary metastases: factors predictive of survival. Neuman HB, Patel A, Hanlon C, Wolchok JD, Houghton AN, Coit DG. Ann Surg Oncol; 2007 Oct 07; 14(10):2847-53. PubMed ID: 17680317 [Abstract] [Full Text] [Related]
27. [Surgical management of orbital malignant melanoma: our experience and a report of three cases]. Poli T, Mora P, Reichegger V, Ricci R, Corradi D, Gandolfi SA, Sesenna E. Klin Monbl Augenheilkd; 2007 Oct 07; 224(10):794-8. PubMed ID: 17952825 [Abstract] [Full Text] [Related]
28. Early outcomes of soft tissue sarcomas presenting with metastases and treated with chemotherapy. King JJ, Fayssoux RS, Lackman RD, Ogilvie CM. Am J Clin Oncol; 2009 Jun 07; 32(3):308-13. PubMed ID: 19433963 [Abstract] [Full Text] [Related]
29. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy]. Qiu MZ, Xu F, Wang SS, Luo HY, Wang F, Li FH, Sun XF, Xu GC, Lin TY, Huang HQ, Jiang WQ, Guan ZZ, Xu RH. Ai Zheng; 2007 Dec 07; 26(12):1344-9. PubMed ID: 18076798 [Abstract] [Full Text] [Related]
30. Outcome of locally recurrent and metastatic angiosarcoma. Lahat G, Dhuka AR, Lahat S, Smith KD, Pollock RE, Hunt KK, Ravi V, Lazar AJ, Lev D. Ann Surg Oncol; 2009 Sep 07; 16(9):2502-9. PubMed ID: 19551444 [Abstract] [Full Text] [Related]
31. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Bedikian AY, Legha SS, Mavligit G, Carrasco CH, Khorana S, Plager C, Papadopoulos N, Benjamin RS. Cancer; 1995 Nov 01; 76(9):1665-70. PubMed ID: 8635073 [Abstract] [Full Text] [Related]
32. Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation. Al-Jamal RT, Eskelin S, Pyrhönen S, Kivelä T. Acta Oncol; 2009 Nov 01; 48(3):476-9. PubMed ID: 19031163 [No Abstract] [Full Text] [Related]
33. Combined liver and pancreas resection with biochemotherapy for metastatic ocular melanoma. Camp R, Lind DS, Hemming AW. J Hepatobiliary Pancreat Surg; 2002 Nov 01; 9(4):519-21. PubMed ID: 12483277 [Abstract] [Full Text] [Related]
34. Melanoma inhibitory activity: a novel serum marker for uveal melanoma. Schaller UC, Bosserhoff AK, Neubauer AS, Buettner R, Kampik A, Mueller AJ. Melanoma Res; 2002 Dec 01; 12(6):593-9. PubMed ID: 12459649 [Abstract] [Full Text] [Related]
35. Possible implications of MCAM expression in metastasis and non-metastatic of primary uveal melanoma patients. Beutel J, Wegner J, Wegner R, Ziemssen F, Nassar K, Rohrbach JM, Hilgers RD, Lüke M, Grisanti S. Curr Eye Res; 2009 Nov 01; 34(11):1004-9. PubMed ID: 19958117 [Abstract] [Full Text] [Related]
36. Gamma-knife-based stereotactic radiosurgery for uveal melanoma. Fakiris AJ, Lo SS, Henderson MA, Witt TC, Worth RM, Danis RP, Des Rosiers PM, Timmerman RD. Stereotact Funct Neurosurg; 2007 Nov 01; 85(2-3):106-12. PubMed ID: 17228176 [Abstract] [Full Text] [Related]
37. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study. Callejo SA, Antecka E, Blanco PL, Edelstein C, Burnier MN. Eye (Lond); 2007 Jun 01; 21(6):752-9. PubMed ID: 16575415 [Abstract] [Full Text] [Related]
38. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO). Dendale R, Lumbroso-Le Rouic L, Noel G, Feuvret L, Levy C, Delacroix S, Meyer A, Nauraye C, Mazal A, Mammar H, Garcia P, D'Hermies F, Frau E, Plancher C, Asselain B, Schlienger P, Mazeron JJ, Desjardins L. Int J Radiat Oncol Biol Phys; 2006 Jul 01; 65(3):780-7. PubMed ID: 16647221 [Abstract] [Full Text] [Related]
39. Malignant melanoma in Turkey: a single institution's experience on 475 cases. Tas F, Kurul S, Camlica H, Topuz E. Jpn J Clin Oncol; 2006 Dec 01; 36(12):794-9. PubMed ID: 17060409 [Abstract] [Full Text] [Related]